Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search


Tensions Building Over AI Billing
October 31, 2025
AI may be accelerating legal work, but it’s also escalating tensions over how that work gets billed — and who benefits from the time saved.
Development
October 31, 2025
Challenge to Positive SEQRA Declaration Not RipeZoning Board of Appeals Failed to Properly Apply Statutory Balancing Test for Area Variance
Second Circuit Gives U.S. Broad Jurisdiction Under Commodities Exchange Act
October 31, 2025
Phillips is another in a line of decisions that expansively permit U.S. prosecutions for conduct taking place overseas, while paying little heed to the extra hardships imposed on defendants forced to defend themselves in a foreign courtroom.
Players On the Move
October 31, 2025
A look at moves among attorneys, law firms, companies and other players in entertainment law.
Note to Associates: Business Development Is Client Service
October 31, 2025
Business development is a set of learnable, repeatable skills that are not reserved for rainmakers. In fact, you won’t get to be a rainmaker without them. If associates start building those skills and habits now, before the expectation hits, you’ll not only be prepared — you’ll be ahead.
Liability Management Exercises: Lender On Lender Violence?
October 31, 2025
Liability management exercises (LMEs) have gained considerable attention during the past few years. Whether intended for good purposes or not, LMEs have significantly disrupted the traditional loan business through aggressive priming and subordination tactics — leading some to characterize this phenomenon as lender-on-lender violence.
UPCOMING EVENT: Copyright Law Year in Review
October 31, 2025
Copyright Law Year in Review, Dec. 11, 2025
Real Estate Practice On the Rise As Clients Commit to AI Data Centers and Office Space
October 31, 2025
Several real estate practice leaders in Big Law are reporting a surge in activity, as their clients commit to more acquisitions, leasing, development and finance deals related to AI data centers and office spaces. As a result, law firm leaders say they are growing these practices with attorney hires.
Firms Getting More Nimble and Efficient In Lateral Hiring to Stay Competitive
October 31, 2025
Even as they become more probing, law firms are also moving faster to make significant lateral hires, according to industry recruiters and consultants.
Report: SEC’s Whistleblower Program At Six-Year Low
October 31, 2025
A powerful incentive to rat out corporate misconduct waned in the latest fiscal year, as payouts under the U.S. Securities and Exchange Commission’s Whistleblower Program fell to their lowest level in six years, a Law.com analysis found.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›